School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, 1211, Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, Rue Michel-Servet 1, 1211, Geneva 4, Switzerland.
Drug Deliv Transl Res. 2024 Dec;14(12):3438-3451. doi: 10.1007/s13346-024-01559-0. Epub 2024 Mar 7.
Nanocrystals and nanosuspensions have become realistic approaches to overcome the formulation challenges of poorly water-soluble drugs. They also represent a less-known but versatile platform for multiple therapeutic applications. They can be integrated into a broad spectrum of drug delivery systems including tablets, hydrogels, microneedles, microparticles, or even functionalized liposomes. The recent progresses, challenges, and opportunities in this field are gathered originally together with an informative case study concerning an itraconazole nanosuspension-in-hydrogel formulation. The translational aspects, historical and current clinical perspectives are also critically reviewed here to shed light on the incoming generation of nanocrystal formulations.
纳米晶体和纳米混悬剂已成为克服水溶性差药物制剂挑战的现实方法。它们也是一个鲜为人知但用途广泛的多功能平台,可用于多种治疗应用。它们可以整合到各种药物输送系统中,包括片剂、水凝胶、微针、微粒,甚至功能化的脂质体。本文汇集了该领域的最新进展、挑战和机遇,并附有一个关于伊曲康唑纳米混悬剂-水凝胶制剂的案例研究,对其进行了信息性介绍。本文还批判性地回顾了转化方面、历史和当前的临床观点,以期为新一代纳米晶体制剂提供启示。